Treatment Registry
TR-0383 ActiveRecorded September 2, 2026Last verified September 3, 2026

Brand tirzepatide

Sold by Aquivia Health · every brand tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

At least $1,399

Medication · Zepbound®, branded, per 4-week fill$1,399
Consultation fee · You are responsible for the full cost of all services and products received through the Platform, including Provider consultation fees, prescription costs, and laboratory fees.charged, amount not published

A charge is disclosed without an amount, so this is a floor. We never count an unpriced charge as zero.

Price

TermPer monthCharged today
Zepbound®, branded, per 4-week fill

$1,399

source, read September 2, 2026

Per month$1,399Charged today$1,399
Visit Aquivia Health

We earn nothing from this link. Aquivia Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

  1. September 2, 2026$1,399
  2. September 3, 2026$1,399
  • September 2, 2026Entry added to the register

Sourcing and terms

PharmacyRedRock Pharmacy; Health Warehouse
Cancellation“Can I stop at any time? Yes. You may stop the program at any time without any long-term commitment. We recommend working with your care team to ensure any transition is handled safely.”
Consult feeCharged, and the amount is not published. You are responsible for the full cost of all services and products received through the Platform, including Provider consultation fees, prescription costs, and laboratory fees.

Not yet checked: states, prescriber and membership.

Recorded from aquiviahealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0383
Readings
2

Related records

What else Aquivia Health sells

All Aquivia Health programs and terms

Brand tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 59 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Aquivia Health brand tirzepatide (TR-0383). Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0383

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.